The American Society of Human Genetics (ASHG) annual meeting 2016 hosted esteemed scientists with a broad array of specialties. The Science Explorer sat in on session #37 on Thursday the 20th of October, and learned about some fascinating new research in the world of hereditary cancer diagnostics. Read the full coverage over at The Science Explorer!…
Tag: health
New Treatments for Niemann-Pick Disease (ASHG 2016 coverage)
At the end of October, The Science Explorer attended some of the sessions at the American Society for Human Genetics annual meeting 2016. One of our favorite presentations was by Dr. Forbes D. Porter of the National Institutes of Health (NIH, US), who talked about a potential new treatment for the debilitating Niemann-Pick disease (NPC). He presented his…
Interview with Michael Schwarzschild -Neurologist at Massachusetts General Hospital
As part of The Science Explorer‘s “Job Spotlight” series, I interviewed Dr. Michael Schwarzschild, who provided some fabulous advice for budding scientists and stressed the importance of having fun along your career path! Read the full interview over at The Science Explorer! Photo credit: Image courtesy of Dr. Michael Schwarzschild / Mass General
NHS England, Unable to Budget for Broad Access, has been Accused of Limiting Access to Hep C Drugs
“The hepatitis C virus (HCV) chronically affects up to 150 million people worldwide. In the UK, an estimated0.5% of the populated are affected. If left untreated, the virus can lead to severe liver damage and sometimes liver cancer. In 2014, two drugs were approved that offer a more than 90% cure rate for HCV; However, the NHS this…
Ecstasy – It Could Treat Thousands but it’s Still Illegal
“MDMA, more commonly referred to as ecstasy, is often thought of as a dangerous Schedule 1 drug – a potentially addictive “club drug” of abuse with no known medical use. But scientists argue that instead of demonising MDMA, we should be studying it for its potential uses in issues related to social behaviour. ” Read more…
Assessing human health from a single drop of blood
Protein levels from vials of whole blood are generally clinically determined using single-protein immunoassays. However, according to research by Geyer et al., a single drop of blood and a mass spectrometer may be all that’s needed to assess human health and disease. Read my review on Geyer et al.’s paper over at Thermo Fisher Scientific’s Accelerating Science Blog….
The Science Writer 